Ipamorelin 10 mg – 10 Vial Box (100mg Total)

Description

Description

Ipamorelin is a synthetic pentapeptide growth hormone secretagogue investigated for its interactions with ghrelin receptor (GHSR-1a) signaling pathways and pituitary somatotroph cell activity. It has been studied for its observed effects on GH pulse amplitude modulation, IGF-1 expression dynamics, and somatostatin inhibition mechanisms in experimental models. Research has noted its selective receptor binding profile, with studies examining its interactions with GHSR-1a in the absence of significant corticotropic or prolactin axis pathway activation compared to other synthetic secretagogues.

For Research Use Only. Not for Human Consumption.

Minimum order quantity: one box (10 vials x 10 mg). 

Note: Product images show branded labels for illustration purposes only. All peptides are shipped in wholesale, unbranded packaging. You can see an actual example photo of the peptide vials and container above.

Specifications

Additional information

Research

1. Raun, Kirsten, et al. "Ipamorelin, the first selective growth hormone secretagogue." European journal of endocrinology 139.5 (1998): 552-561.
2. Andersen, N. B., et al. "The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats." Growth Hormone & IGF Research 11.5 (2001): 266-272.
3. Beck, David E., et al. "Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients." International journal of colorectal disease 29 (2014): 1527-1534.
4. Gobburu, Jogarao VS, et al. "Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers." Pharmaceutical research 16 (1999): 1412-1416.

Testing Docs